GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (FRA:SBS) » Definitions » Cyclically Adjusted Price-to-FCF

Stratec SE (FRA:SBS) Cyclically Adjusted Price-to-FCF : 49.26 (As of Jun. 10, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Stratec SE Cyclically Adjusted Price-to-FCF?

As of today (2024-06-10), Stratec SE's current share price is €46.30. Stratec SE's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.94. Stratec SE's Cyclically Adjusted Price-to-FCF for today is 49.26.

The historical rank and industry rank for Stratec SE's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:SBS' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.21   Med: 73.55   Max: 186.39
Current: 49.19

During the past years, Stratec SE's highest Cyclically Adjusted Price-to-FCF was 186.39. The lowest was 36.21. And the median was 73.55.

FRA:SBS's Cyclically Adjusted Price-to-FCF is ranked worse than
58.47% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 42.675 vs FRA:SBS: 49.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Stratec SE's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-0.154. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.94 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stratec SE Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Stratec SE's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Cyclically Adjusted Price-to-FCF Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.17 152.53 119.51 69.86 43.00

Stratec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.24 59.85 42.91 43.00 41.76

Competitive Comparison of Stratec SE's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Stratec SE's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Stratec SE's Cyclically Adjusted Price-to-FCF falls into.



Stratec SE Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Stratec SE's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=46.30/0.94
=49.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stratec SE's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Stratec SE's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.154/125.0381*125.0381
=-0.154

Current CPI (Mar. 2024) = 125.0381.

Stratec SE Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.467 99.543 0.587
201409 0.569 99.823 0.713
201412 1.108 99.543 1.392
201503 0.754 99.717 0.945
201506 0.029 100.417 0.036
201509 0.562 100.417 0.700
201512 0.099 99.717 0.124
201603 0.000 100.017 0.000
201606 0.000 100.717 0.000
201609 0.000 101.017 0.000
201612 0.000 101.217 0.000
201703 0.907 101.417 1.118
201706 -0.298 102.117 -0.365
201709 0.738 102.717 0.898
201712 -0.148 102.617 -0.180
201803 0.668 102.917 0.812
201806 -0.310 104.017 -0.373
201809 -0.122 104.718 -0.146
201812 -0.858 104.217 -1.029
201903 0.209 104.217 0.251
201906 -0.300 105.718 -0.355
201909 -0.673 106.018 -0.794
201912 0.300 105.818 0.354
202003 -0.325 105.718 -0.384
202006 0.351 106.618 0.412
202009 0.064 105.818 0.076
202012 0.422 105.518 0.500
202103 0.797 107.518 0.927
202106 1.084 108.486 1.249
202109 1.003 109.435 1.146
202112 0.667 110.384 0.756
202203 -0.259 113.968 -0.284
202206 1.639 115.760 1.770
202209 -0.547 118.818 -0.576
202212 -1.552 119.345 -1.626
202303 0.070 122.402 0.072
202306 -0.481 123.140 -0.488
202309 0.141 124.195 0.142
202312 0.434 123.773 0.438
202403 -0.154 125.038 -0.154

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stratec SE  (FRA:SBS) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Stratec SE Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Stratec SE's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (FRA:SBS) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.